Back to News
Market Impact: 0.3

Before You Buy the Dip on Costco Stock, Here Are 3 Things to Watch in 2026

COSTNFLXNVDANDAQ
Consumer Demand & RetailCompany FundamentalsCorporate Guidance & OutlookCorporate EarningsInvestor Sentiment & PositioningAnalyst InsightsEmerging Markets
Before You Buy the Dip on Costco Stock, Here Are 3 Things to Watch in 2026

Costco continues to report resilient same-store sales (fiscal 2020 +7.7%, fiscal 2021 +16%, fiscal 2022 +14.4%) and posted Q1 fiscal 2026 net sales of $66 billion, with fiscal 2025 net sales and net income up 8% and 10% year-over-year respectively. Management plans 28 net new warehouses in fiscal 2026 and sees further international expansion opportunities (notably China), but the stock trades at an elevated multiple (P/E ~46, down from ~63 earlier in 2025) and is roughly 6% lower year-to-date (and ~20% off its peak), leaving a tradeoff between durable fundamentals and valuation for investors.

Analysis

Market structure: Costco (COST) is a clear winner — its membership model and rising same-store sales (SSS) signal durable pricing power and stable gross margins vs. traditional grocers and discounters that face margin compression. Suppliers of bulk goods and private-label partners also benefit from predictable large-volume purchasing; small-format grocers and low-margin supermarkets are the relative losers as share shifts toward warehouse formats. Resilient SSS (single-digit+ growth in recent years) implies demand > supply for warehouse-format bulk retail, supporting inventories and keeping commodity passthrough intact. Risk assessment: Tail risks include a China regulatory/backlash event that stalls international openings, an unexpected membership churn >5ppt, or a sharp wage/transport cost shock compressing EBIT margins by >200bps. Immediate (days) risk: multiple compression and sentiment-driven downside; short-term (weeks/months): SSS prints and Q2 guidance; long-term (quarters/years): realization of 28 net new warehouses in FY26 and sustained membership renewals. Hidden dependency: margin resilience rests on gas/convenience fuel margins and membership fee trend — both are leading indicators of membership health. Trade implications: Direct: consider a core 2–3% long position in COST if P/E ≤45 or stock is down ≥15% from 52-week high, targeting +15–25% in 9–12 months. Pair trade: long COST vs short WMT (equal notional) when trailing-12m SSS spread >5ppt for two consecutive quarters; this isolates model advantage. Options: buy 9–12 month LEAP calls (delta ~0.6) to gain convexity or sell 2–3 month covered calls to harvest income if you already own shares. Rotate modestly into consumer staples/warehouse retail and trim high-valuation discretionary exposure. Contrarian angles: Consensus underweights the optionality from international expansion and membership fee leverage — if membership revenue grows +5% y/y and renewal stays >88%, EPS re-rate is plausible from current P/E ~46 to 50–55 within 12 months. The market may be over-penalizing valuation without accounting for steady free cash flow and 28 planned FY26 openings; conversely, overexpansion in China or a meaningful membership shock would materially reverse thesis. Historical parallels: COST has rebounded within 6–12 months after prior multiple contractions when SSS regained momentum, suggesting a timing edge for patient accumulation.